Gene · 571
Papers2,758
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,061 to 1,080 of 2,758
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Aged Garlic Extract Reduces IL-6: A Double-Blind Placebo-Controlled Trial in Females with a Low Risk of Cardiovascular Disease. | Evid Based Complement Alternat Med | 2021 | 33868439 | PubTator, text mining | PubMed |
| The Anti-Inflammatory Properties of Phytochemicals and Their Effects on Epigenetic Mechanisms Involved in TLR4/NF-κB-Mediated Inflammation. | Front Immunol | 2021 | 33868227 | PubTator, text mining | PubMed |
| Brd4-bound enhancers drive cell-intrinsic sex differences in glioblastoma. | Proc Natl Acad Sci U S A | 2021 | 33850013 | PubTator, text mining | PubMed |
| miR-155 Contributes to the Immunoregulatory Function of Human Mesenchymal Stem Cells. | Front Immunol | 2021 | 33841404 | PubTator, text mining | PubMed |
| Targeting Nrf2-Mediated Oxidative Stress Response Signaling Pathways as New Therapeutic Strategy for Pituitary Adenomas. | Front Pharmacol | 2021 | 33841137 | PubTator, text mining | PubMed |
| Cardiovascular RNA markers and artificial intelligence may improve COVID-19 outcome: a position paper from the EU-CardioRNA COST Action CA17129. | Cardiovasc Res | 2021 | 33839767 | PubTator, text mining | PubMed |
| CircRNA circBACH1 (hsa_circ_0061395) serves as a miR-656-3p sponge to facilitate hepatocellular carcinoma progression through increasing SERBP1 expression. | Biochem Biophys Res Commun | 2021 | 33831787 | PubTator, text mining | PubMed |
| Cooperation between NRF2-mediated transcription and MDIG-dependent epigenetic modifications in arsenic-induced carcinogenesis and cancer stem cells. | Semin Cancer Biol | 2021 | 33823236 | PubTator, text mining | PubMed |
| Testing in vitro tools for the prediction of cholestatic liver injury induced by non-pharmaceutical chemicals. | Food Chem Toxicol | 2021 | 33819548 | PubTator, text mining | PubMed |
| Potential Mechanism Underlying the Role of Mitochondria in Breast Cancer Drug Resistance and Its Related Treatment Prospects. | Front Oncol | 2021 | 33816265 | PubTator, text mining | PubMed |
| Understanding the function of the tumor microenvironment, and compounds from marine organisms for breast cancer therapy. | World J Biol Chem | 2021 | 33815682 | PubTator, text mining | PubMed |
Expression of nuclear factor erythroid-2-related factor 2, broad complex-tramtrack-bric a brac and Cap'n'collar homology 1 and γ-glutamic acid cysteine synthase in peripheral blood of patients with chronic obstructive pulmonary disease and its clinical significance. | Exp Ther Med | 2021 | 33815589 | PubTator, text mining | PubMed |
| Transcriptome and IgH Repertoire Analyses Show That CD11chi B Cells Are a Distinct Population With Similarity to B Cells Arising in Autoimmunity and Infection. | Front Immunol | 2021 | 33815408 | PubTator, text mining | PubMed |
| A Novel Therapeutic Target, BACH1, Regulates Cancer Metabolism. | Cells | 2021 | 33809182 | PubTator, text mining | PubMed |
| Iron-Bound Lipocalin-2 from Tumor-Associated Macrophages Drives Breast Cancer Progression Independent of Ferroportin. | Metabolites | 2021 | 33808732 | PubTator, text mining | PubMed |
| Role of HO-1 against Saturated Fatty Acid-Induced Oxidative Stress in Hepatocytes. | Nutrients | 2021 | 33808635 | PubTator, text mining | PubMed |
| Insight into the Key Points of Preeclampsia Pathophysiology: Uterine Artery Remodeling and the Role of MicroRNAs. | Int J Mol Sci | 2021 | 33808559 | PubTator, text mining | PubMed |
| MicroRNA Interference in Hepatic Host-Pathogen Interactions. | Int J Mol Sci | 2021 | 33808062 | PubTator, text mining | PubMed |
| Therapeutic Targeting of the NRF2 Signaling Pathway in Cancer. | Molecules | 2021 | 33808001 | PubTator, text mining | PubMed |
| Control of Oxidative Stress in Cancer Chemoresistance: Spotlight on Nrf2 Role. | Antioxidants (Basel) | 2021 | 33805928 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/571/papers?page=54